Empowered Relief Class for Chronic Pain
(ER-Y Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate how a single-session pain management class, called Empowered Relief for Youth, can help young people understand and manage chronic pain. The class will teach pain science and self-regulation techniques to improve pain management. Researchers will assess the class's reception and initial effectiveness through surveys over three months. Children and teens aged 10 to 18 with chronic pain who speak English may be suitable for this trial. As an unphased trial, this study offers participants a unique opportunity to contribute to innovative pain management strategies for youth.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this class is safe for youth with chronic pain?
Research has shown that the Empowered Relief class is a well-accepted method for managing chronic pain. One study found that a single session of Empowered Relief had effects similar to an 8-session cognitive behavioral therapy, even six months later. This suggests it can be both effective and manageable for participants.
In another study involving 172 teenagers with chronic pain or fatigue, nearly half experienced positive results after treatment. This underscores the potential benefits of this method for young people.
Empowered Relief does not involve medication or physical treatments, reducing the likelihood of side effects. Instead, it focuses on teaching participants about pain and self-management, making it a safe option for many.12345Why are researchers excited about this trial?
Researchers are excited about the Empowered Relief for Youth because it offers a fresh approach to managing chronic pain by focusing on education and self-regulation skills. Unlike traditional treatments that often rely on medication or ongoing therapy sessions, this is a single-session class that teaches pain science and self-management techniques. This innovative method empowers young individuals to understand and manage their pain independently, potentially reducing reliance on medications and enhancing their quality of life.
What evidence suggests that Empowered Relief for Youth is effective for chronic pain?
Studies have shown that Empowered Relief, a one-time class teaching pain management skills, works as well as an eight-session therapy program for reducing chronic low back pain. It reduces "pain catastrophizing," altering how much pain bothers individuals. This program also positively affects pain levels and sleep issues. In this trial, participants will receive the Empowered Relief for Youth class to determine if this approach can help young people manage chronic pain by educating them about pain and control strategies. While researchers are still collecting specific data for young people, the success in adults is promising.12678
Who Is on the Research Team?
Laura Simons, PhD
Principal Investigator
Stanford University
Are You a Good Fit for This Trial?
This trial is for English-speaking youths aged 10 to 18 who have been diagnosed with various types of chronic pain, including neuropathic pain and fibromyalgia. It's not suitable for those with neurological conditions like seizures or severe mental health issues such as intense depression or anxiety.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants attend a single-session pain management class focused on pain science education and self-regulatory skills
Follow-up
Participants are monitored for feasibility, acceptability, and preliminary efficacy through surveys
What Are the Treatments Tested in This Trial?
Interventions
- Empowered Relief for Youth
Empowered Relief for Youth is already approved in United States for the following indications:
- Chronic pain management in youth
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor